Dinesh Mishra

Dinesh Mishra

Novartis Institutes for BioMedical Research - Bhubaneswar / United States
Economics & Econometrics / Economics
AD Scientific Index ID: 4540072
-
person_outline Dinesh Mishra's MOST POPULAR ARTICLES
1-) Cost-effectiveness of ribociclib plus letrozole versus palbociclib plus letrozole and letrozole monotherapy in the first-line treatment of postmenopausal women with HR+/HER2 …R Mistry, JR May, G Suri, K Young, D Brixner, G Oderda, J Biskupiak, ...Journal of managed care & specialty pharmacy 24 (6), 514-523, 2018522018
2-) An ethnomedicinal study among the Gond of Chhattisgarh: IndiaD Mishra, A BrokerAntrocom 5 (1), 61-65, 2009162009
3-) Cost-effectiveness of dabrafenib and trametinib in combination as adjuvant treatment of BRAF V600E/K mutation-positive melanoma from a US healthcare payer perspectiveME Gerbasi, D Stellato, SR Ghate, B Ndife, A Moynahan, D Mishra, ...Journal of Medical Economics 22 (12), 1243-1252, 2019122019
4-) Cost-effectiveness of secukinumab compared to other biologics in the treatment of ankylosing spondylitis in FinlandT Purmonen, K Puolakka, D Mishra, P Gunda, J MartikainenClinicoEconomics and Outcomes Research, 159-168, 2019142019
5-) Budget impact of capmatinib for adults with metastatic non-small cell lung cancer harboring a MET exon 14 skipping mutation in the United StatesB Cai, ZY Zhou, W Xue, NC Hazra, M Singh, D Mishra, D Brixner, ...Journal of Medical Economics 24 (1), 131-139, 2021122021